Manuscripts
Showing 1543 manuscripts.
A Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-infected Infants and Children
Citation
Walter T. Hughes, Alejandro Dorenbaum, Ram Yogev, B. Beauchamp, Jing Xu, James McNamara, John ( Jack ) Moye, Lynette Purdue, Russell B. Van Dyke, Martha Rogers, Brian M. Sadler. A Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-infected Infants and Children. Antimicrobial Agents and Chemotherapy. 1998. 42: 1315-18.Year
1998
Journal
Antimicrobial Agents and Chemotherapy
Correspondence (Reply): Safety and Pharmocokinetics Of Hyperimmune Anti-HIV Immunoglobulin (HIVIG) Administered To HIV-Infected Pregnant Women and Their Newborns
Citation
Lambert J, Mofenson LM, Moye J. Correspondence (Reply): Safety and Pharmocokinetics Of Hyperimmune Anti-HIV Immunoglobulin (HIVIG) Administered To HIV-Infected Pregnant Women and Their Newborns. Journal of Infectious Diseases. 1998. 178: 598-99.Year
1998
Journal
Journal of Infectious Diseases
Antiretroviral Therapy and Medical Management Of Pediatric HIV Infection
Citation
Oleske JM. Antiretroviral Therapy and Medical Management Of Pediatric HIV Infection. Pediatrics. 1998. 102: 1005-56.Year
1998
Journal
Pediatrics
Cartesian coordinate analysis of viral burden and CD4+ T-cell count in human immunodeficiency virus type-1 infection
Citation
Patricia Reichelderfer, Robert W. Coombs. Cartesian coordinate analysis of viral burden and CD4+ T-cell count in human immunodeficiency virus type-1 infection. Antiviral Research. 1998. 38: 181-94.Year
1998
Journal
Antiviral Research
Primary human immunodeficiency virus type 1 infection during pregnancy associated with transmission of SI/MT-2 cell tropic virus and precipitous loss of CD4 cells in mother and infant
Citation
Lorenz Von Seidlein, Susan Plaeger, Ruth E. Dickover, Paul Krogstad, E. Richard Stiehm, Yvonne J. Bryson. Primary human immunodeficiency virus type 1 infection during pregnancy associated with transmission of SI/MT-2 cell tropic virus and precipitous loss of CD4 cells in mother and infant. Pediatric Infectious Disease Journal. 1998. 17: 528-30.Year
1998
Journal
Pediatric Infectious Disease Journal
Estimating a treatment effect from multidimensional longitudinal data
Citation
Sarah M. Gray, Ronald Brookmeyer. Estimating a treatment effect from multidimensional longitudinal data. Biometrics. 1998. 54: 976-88.Year
1998
Journal
Biometrics
Combination Treatment with Zidovudine, Didanosine, and Nevirapine in Infants with Human Immunodeficiency Virus Type 1 Infection
Citation
Krogstad P, Luzuriaga K, Bryson Y, Robinson J, Stechenberg B, Lamson M, Sullivan JL. Combination Treatment with Zidovudine, Didanosine, and Nevirapine in Infants with Human Immunodeficiency Virus Type 1 Infection. New England Journal of Medicine. 1997. 336: 1343-1349.Year
1997
Journal
New England Journal of Medicine
Vertical Transmission of HIV in New York State: A Basis for Statewide Testing of Newborns
Citation
Nancy Wade, Leonard Weiner, Lisa Frenkel, Mahrukh Bamji, Asha Gupta. Vertical Transmission of HIV in New York State: A Basis for Statewide Testing of Newborns. AIDS Patient Care and STDs. 1997. 11: 227-236.Year
1997
Journal
AIDS Patient Care and STDs
Reducing the Risk Of Perinatal HIV-1 Transmission With Zidovudine: Results and Implications Of AIDS Clinical Trials Group Protocol 076
Citation
Mofenson LM. Reducing the Risk Of Perinatal HIV-1 Transmission With Zidovudine: Results and Implications Of AIDS Clinical Trials Group Protocol 076. ACTA Paediatrica. 1997. 86: 89-96.Year
1997
Journal
ACTA Paediatrica
Cross-sectional and longitudinal evaluation of body composition in men with HIV infection
Citation
Kathleen Mulligan, Viva W. Tai, Morris Schambelan. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. Journal of Acquired Immune Deficiency Syndromes. 1997. 15: 43-48.Year
1997
Journal
Journal of Acquired Immune Deficiency Syndromes